| Literature DB >> 27488366 |
Flavio H F Galvão1, Daniel R Waisberg1, Victor E Seid1, Anderson C L Costa2, Eleazar Chaib1, Rachel Rossini Baptista1, Vera Luiza Capelozzi2, Cinthia Lanchotte1, Ruy J Cruz3, Jun Araki4, Luiz Carneiro D'Albuquerque1.
Abstract
Fecal incontinence is a challenging condition with numerous available treatment modalities. Success rates vary across these modalities, and permanent colostomy is often indicated when they fail. For these cases, a novel potential therapeutic strategy is anorectal transplantation (ATx). We performed four isogeneic (Lewis-to-Lewis) and seven allogeneic (Wistar-to-Lewis) ATx procedures. The anorectum was retrieved with a vascular pedicle containing the aorta in continuity with the inferior mesenteric artery and portal vein in continuity with the inferior mesenteric vein. In the recipient, the native anorectal segment was removed and the graft was transplanted by end-to-side aorta-aorta and porto-cava anastomoses and end-to-end colorectal anastomosis. Recipients were sacrificed at the experimental endpoint on postoperative day 30. Surviving animals resumed normal body weight gain and clinical performance within 5 days of surgery. Isografts and 42.9% of allografts achieved normal clinical evolution up to the experimental endpoint. In 57.1% of allografts, signs of immunological rejection (abdominal distention, diarrhea, and anal mucosa inflammation) were observed three weeks after transplantation. Histology revealed moderate to severe rejection in allografts and no signs of rejection in isografts. We describe a feasible model of ATx in rats, which may allow further physiological and immunologic studies.Entities:
Mesh:
Year: 2016 PMID: 27488366 PMCID: PMC4973224 DOI: 10.1038/srep30894
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Surgical procedures of anorectal transplantation.
(A) Anorectal segment mobilized to the inside of the abdominal wall, preserving the inferior mesenteric artery (IMA). (A) anus; Ao, abdominal aorta; LCIA and RCIA, left and right common iliac artery, respectively; R, rectum. (B) Superior mesenteric vein (SMV) and portal tributaries divided during graft removal. The inferior mesenteric vein (IMV) is preserved. (C) colon; LGV, left gastric vein; MCV, middle colic vein; SV, splenic vein. (C) Graft containing the anorectal segment with a vascular pedicle including the abdominal aorta (Ao) in continuity with the inferior mesenteric artery (IMA) and the portal vein (PV) in continuity with the inferior mesenteric vein (IMV) to enhance the vessels diameter to simplify the anastomosis. (A) anus; R, rectum. (D) Graft macroscopic aspect following reperfusion. (A) anus; AMC, aortomesenteric conduit; AoR, recipient’s abdominal aorta; (C) colon; IVC, inferior vena cava; PV, portal vein; R, rectum.
Histologic principles for classifying anorectal allograft acute rejection.
| Grade | Histologic Findings |
|---|---|
| Indeterminate for ACR | Rectum–Mucosa, submucosa and muscular layers with minimum lymphocytic infiltration and edema and no crypt epithelial injury and no ulceration. Increased crypt cell apoptosis, but with less than six apoptotic bodies per 10 crypts.Anal channel–Minimum lymphocytic infiltrate and edema in mucosa, submucosa and both internal and external anal sphincters.Perianal skin–Minimum subepidermic lymphocytic infiltrate. |
| Mild rejection | Rectum–Altered mucosae architecture (e.g. mild villi blunting) with minor activated lymphocytic inflammatory infiltration predominantly in the lamina propria, rare crypt epithelial injury and no ulceration, submucosa and muscular layers with slight activated lymphocytic infiltrate and edema. Increased crypt cell apoptosis (>6 six apoptotic bodies/10 crypts).Anal channel–Incipient activated lymphocytic infiltrate and edema in mucosa, submucosa and both internal and external anal sphincters.Perianal skin–mild subepidermic lymphocytic inflammatory infiltrate. |
| Moderate rejection | Rectum–Mucosa, submucosa and muscular layers revealing disseminated activated lymphocytic infiltration, edema and increased crypt epithelial injury and apoptosis. Increased crypt cell apoptosis (>6 six apoptotic bodies/10 crypts), accompanied by foci of confluent apoptosis.Anal channel–Mucosa submucosa and both internal and external anal sphincters with intense lymphocytic infiltrate and diffuse edema, important epithelium and gland atrophy and sites of necrosis, arterites and ulceration.Perianal skin–Severe epidermic and subepidermic activated lymphocytic inflammatory infiltrate, moderate squamous epithelium atrophy architectural distortion. All grafts segments showed places of moderate architectural alteration. |
| Severe rejection | Rectum–Mucosa, submucosa and muscular layers exhibiting widely disseminated activated lymphocytic infiltration, intense crypt epithelial injury, diffuse apoptosis, important edema, transmural necrosis and ulceration.Anal channel–Mucosa submucosa and both internal and external anal sphincters with intense activated lymphocytic infiltrate and edema, important epithelium and gland atrophy and sites of necrosis.Perianal skin–Severe epidermic and subepidermic lymphocytic infiltrate, marked atrophy in the squamous epithelium. All grafts segments showed important and diffuse architectural distortion. |
ACR–Acute cellular rejection.
Figure 2Postoperative immunological rejection of allogeneic anorectal tansplantation.
(A) Macroscopic aspect of the anus 21 days after allotransplantation showing hyperemia and signs of rejection. (B,C) Histopathology of the anus showing lymphocytic infiltration in both the internal and the external anal sphincters. (D,E) Histopathology of the rectum showing severe rejection with villous damage in the superficial mucosa and considerable amounts of lymphocytic cryptitis, vasculitis, and necrosis.
Model of acute celular rejection grade in anorectal allograft.
| Type of the Transplant | Weight loss >10% | Complication | POD | Histological rejection grade |
|---|---|---|---|---|
| Isogeneic transplant ( | no | none | — | None |
| no | none | — | None | |
| no | none | — | None | |
| yes | Death 5th POD | — | — | |
| Allogeneic transplant | no | none | — | Moderate |
| no | none | — | Moderate | |
| no | none | — | Moderate | |
| no | Diarrhea, Abd distension | 18th | Severe | |
| no | Abd distention, Anal hyperemia | 21st | Severe | |
| no | Abd distention, Anal hyperemia | 22nd | Severe | |
| no | Anal hyperemia | 27th | Severe |
Recipient characteristics, clinical evolution, and histological findings of 11 rats that underwent microsurgical isogeneic or allogeneic anorectal transplantation. Abbreviations: POD = postoperative day; W = Wistar; L = Lewis.